Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Haverkate

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|May 9, 1981
[Familial dysfibrinogenemia; fibrinogen Haarlem I and II]A Hensen, E J Brommer, M Gravesen, et al.
Advances in Experimental Medicine and Biology|January 1, 1990
Protein C and fibrinolysis: a link between coagulation and fibrinolysisN J de Fouw, F Haverkate, R M Bertina
Blood|August 1, 1986
Production and characterization of a monoclonal antibody reactive with a specific neoantigenic determinant (comprising B beta 54-118) in degradation products of fibrin and of fibrinogenP W Koppert, J Koopman, F Haverkate, et al.
Thrombosis and Haemostasis|April 25, 1989
The measurement of haemostatic factors in 16 European laboratories: quality assessment for the Multicentre ECAT Angina Pectoris Study. Report from the European Concerted Action on Thrombosis and Disabilities (ECAT)S G Thompson, F Duckert, F Haverkate, et al.
Biochimica Et Biophysica Acta|October 5, 1982
A fibrinogen fragment D (D intermediate) with calcium binding but without anticlotting propertiesW Nieuwenhuizen, M Voskuilen, A Vermond, et al.
Annals of Epidemiology|July 1, 1992
The relationship between hemostatic tests and cardiovascular risk factors in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris GroupF Haverkate, S G Thompson, J C van de Loo
American Journal of Clinical Pathology|December 1, 1975
Fibrinolytic activity in aneurysmal bone cystsD J Ruiter, J Lindeman, F Haverkate, et al.
Thrombosis Research|August 1, 1985
Protraction of whole blood and plasma clot lysis in patients with high levels of an inhibitor of tissue-type plasminogen activatorE J Brommer, A L Boks, J Koopman, et al.
Blood|October 15, 1992
Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461-610 (Lys 461 AAA-->stop TAA)J Koopman, F Haverkate, J Grimbergen, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
The long-term within- and between-laboratory variability for assay of antithrombin, and proteins C and S: results derived from the external quality assessment program for thrombophilia screening of the ECAT FoundationP Meijer, C Kluft, F Haverkate, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Nederlands Tijdschrift Voor Geneeskunde|May 9, 1981
[Familial dysfibrinogenemia; fibrinogen Haarlem I and II]A Hensen, E J Brommer, M Gravesen, et al.
Advances in Experimental Medicine and Biology|January 1, 1990
Protein C and fibrinolysis: a link between coagulation and fibrinolysisN J de Fouw, F Haverkate, R M Bertina
Blood|August 1, 1986
Production and characterization of a monoclonal antibody reactive with a specific neoantigenic determinant (comprising B beta 54-118) in degradation products of fibrin and of fibrinogenP W Koppert, J Koopman, F Haverkate, et al.
Thrombosis and Haemostasis|April 25, 1989
The measurement of haemostatic factors in 16 European laboratories: quality assessment for the Multicentre ECAT Angina Pectoris Study. Report from the European Concerted Action on Thrombosis and Disabilities (ECAT)S G Thompson, F Duckert, F Haverkate, et al.
Biochimica Et Biophysica Acta|October 5, 1982
A fibrinogen fragment D (D intermediate) with calcium binding but without anticlotting propertiesW Nieuwenhuizen, M Voskuilen, A Vermond, et al.
Annals of Epidemiology|July 1, 1992
The relationship between hemostatic tests and cardiovascular risk factors in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris GroupF Haverkate, S G Thompson, J C van de Loo
American Journal of Clinical Pathology|December 1, 1975
Fibrinolytic activity in aneurysmal bone cystsD J Ruiter, J Lindeman, F Haverkate, et al.
Thrombosis Research|August 1, 1985
Protraction of whole blood and plasma clot lysis in patients with high levels of an inhibitor of tissue-type plasminogen activatorE J Brommer, A L Boks, J Koopman, et al.
Blood|October 15, 1992
Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461-610 (Lys 461 AAA-->stop TAA)J Koopman, F Haverkate, J Grimbergen, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
The long-term within- and between-laboratory variability for assay of antithrombin, and proteins C and S: results derived from the external quality assessment program for thrombophilia screening of the ECAT FoundationP Meijer, C Kluft, F Haverkate, et al.
Pageof 8